PRIME-HCC Trial
PRIME-HCC is a pragmatic two-arm parallel randomised controlled trial evaluating ePRO-based symptom monitoring for HCC patients receiving immunotherapy in China. The trial evaluates both clinical effectiveness and implementation outcomes.
1 sources - 6 claims
PRIME-HCC is a pragmatic two-arm parallel randomised controlled trial evaluating ePRO-based symptom monitoring for HCC patients receiving immunotherapy in China. The trial evaluates both clinical effectiveness and implementation outcomes.